Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin--a mini-review
about
Tyrosinase inhibitory properties of phenylpropanoid glycosides and flavonoids from Teucrium polium L. var. gnaphalodesHesperetin induces apoptosis of esophageal cancer cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species.Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.Prooxidant Activity of Polyphenols, Flavonoids, Anthocyanins and Carotenoids: Updated Review of Mechanisms and Catalyzing Metals.Simultaneous administration of hesperidin or garlic oil modulates diazinon-induced hemato- and immunotoxicity in rats.Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.Hesperidin attenuates learning and memory deficits in APP/PS1 mice through activation of Akt/Nrf2 signaling and inhibition of RAGE/NF-κB signaling.Long-term Treatment with Hesperidin Improves Endothelium-dependent Vasodilation in Femoral Artery of Spontaneously Hypertensive Rats: The Involvement of NO-synthase and Kv Channels.Hesperidin Alleviates Oxidative Stress and Upregulates the Multidrug Resistance Protein 2 in Isoniazid and Rifampicin-Induced Liver Injury in Rats.Advances in the Preclinical Study of Some Flavonoids as Potential Antidepressant Agents.Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability.Multifunctional Actions of Ninjinyoeito, a Japanese Kampo Medicine: Accumulated Scientific Evidence Based on Experiments With Cells and Animal Models, and Clinical StudiesHesperidin protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes
P2860
Q28822578-8250A003-8180-438C-B4C0-373BCC894602Q35800984-EE010043-C87F-49D3-9AA0-8964F324647AQ38581733-4ECF1DE4-9A2C-4F21-A512-C29434E390E0Q38848467-9ED98398-3571-4188-BD08-73E170EF2111Q40322093-28E4BCAC-4945-4AB1-98A5-5DA6719ABFF3Q48064443-E053D2DA-8B22-4380-98D3-C65822777C9DQ49106681-2F2F6372-521D-40BB-9107-4B5A913201BFQ50560077-D488DE54-F970-4C5A-ABAE-EAD5542E3C88Q53777118-87C83076-53A7-47BF-8327-FA59217C20D1Q53791952-8B3622AF-7773-4D05-B886-0E32DC94FB45Q54117325-2C7BC202-D50E-4D3B-8500-CFCFE6A1AE34Q55421736-D602A089-FF07-413D-BCC7-027F8EFACD73Q57817582-BDC0AA05-9A6D-452E-AD78-B7463FCDAFE9Q58733394-D924F477-FC98-4940-A2E2-58EF75D0E636
P2860
Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin--a mini-review
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Neuropharmacological propertie ...... and hesperetin--a mini-review
@ast
Neuropharmacological propertie ...... and hesperetin--a mini-review
@en
Neuropharmacological propertie ...... and hesperetin--a mini-review
@nl
type
label
Neuropharmacological propertie ...... and hesperetin--a mini-review
@ast
Neuropharmacological propertie ...... and hesperetin--a mini-review
@en
Neuropharmacological propertie ...... and hesperetin--a mini-review
@nl
prefLabel
Neuropharmacological propertie ...... and hesperetin--a mini-review
@ast
Neuropharmacological propertie ...... and hesperetin--a mini-review
@en
Neuropharmacological propertie ...... and hesperetin--a mini-review
@nl
P50
P1433
P1476
Neuropharmacological propertie ...... and hesperetin--a mini-review
@en
P2093
Hamideh Parhiz
P356
10.1016/J.LFS.2014.07.029
P407
P577
2014-08-07T00:00:00Z